Status:
COMPLETED
Methotrexate in the Treatment of Distal Interphalangeal Joint Extensor Tendon Enthesopathy in Nail Psoriasis
Lead Sponsor:
Ryszard Górecki
Conditions:
Nail Psoriasis
Eligibility:
All Genders
34-57 years
Brief Summary
The primary aim of the study is to assess the effect of methotrexate on the development of distal interphalangeal joint extensor tendon enthesopathy.
Detailed Description
Nail psoriasis is one of the risk factors for psoriatic arthritis (PsA), especially with distal interphalangeal joints affected. Nail changes in psoriasis have been observed in 10-55% of patients, and...
Eligibility Criteria
Inclusion
- Patients with psoriatic changes in nails treated at the Rheumatological Clinic in Olsztyn and the Clinic of Dermatology, Sexually Transmitted Diseases and Clinical Immunology of the University of Warmia and Mazury in Olsztyn, in whom a US examination revealed DIP joint extensor tendon enthesopathy
Exclusion
- Patients diagnosed with osteoarthritis of hands, those who work hard physically and those with changes in nails other than caused by psoriasis
Key Trial Info
Start Date :
January 7 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2018
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT03757364
Start Date
January 7 2018
End Date
September 30 2018
Last Update
November 28 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Warmia and Mazury
Olsztyn, Warmian-Masurian Voivodeship, Poland, 10-900